Top

BMC Medical Genetics

Published in:

Open Access 01-12-2014 | Research article

Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria

Authors: Qi Liu, Zhen Wang, Yuhong Wu, Lihua Cao, Qingzhu Tang, Xuesha Xing, Hongwei Ma, Shifa Zhang, Yang Luo

Published in: BMC Medical Genetics | Issue 1/2014

Abstract

Background

Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominantly inherited skin disease associated with mutations of ADAR1, the gene that encodes a double-stranded RNA-specific adenosine deaminase. The purpose of this study was to investigate the potential mutations in ADAR1 in seven Chinese families with DSH.

Methods

All the coding exons including adjacent intronic as well as 5′ and 3′ untranslated region (UTR) of ADAR1 were screened by direct sequencing. Moreover, quantitative reverse-transcription polymerase chain (qRT-PCR) and Western blot were applied to determine the pathogenic effects associated with the mutations.

Results

Molecular genetic investigations detected five novel mutations (c.556C > T, c.3001C > T, c.1936_1937insTG, c.1065_1068delGACA and c.1601G > A resulting in p.Gln186X, p.Arg1001Cys, p.Phe646LeufsX16, p.Asp357ArgfsX47 and p.Gly471AspfsX30 protein changes, respectively) as well as two previously reported (c.2744C > T and c.3463C > T causing p.Ser915Phe and p.Arg1155Trp protein changes, respectively). Among them, we found that the substitution c.1601G > A at the last nucleotide of exon 2 compromised the recognition of the splice donor site of intron 2, inducing an aberrant transcript with 190-bp deletion in exon 2 and causing an approximately 50% reduction of ADAR1 mRNA level in affected individual. In addition, consistent with the predicted results, the expression patterns of other novel mutations were detected by Western blot.

Conclusion

We identified five novel and two recurrent mutations of the ADAR1 gene in seven Chinese families with DSH and investigated potential effects of the novel mutations in this study. Our study expands the database on mutations of ADAR1 and for the first time, demonstrates the importance of exonic nucleotides at exon-intron junctions for ADAR1 splicing.

Available only for authorised users

Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y: Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet. 2003, 73: 693-699.CrossRefPubMedPubMedCentral

Suzuki N, Suzuki T, Inagaki K, Ito S, Kono M, Horikawa T, Fujiwara S, Shiko A, Matsunaga K, Aoyama Y, Tosaki-Ichikawa H, Tomita Y: Ten novel mutations of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria. J Invest Dermatol. 2007, 127: 309-311.CrossRefPubMed

Kondo T, Suzuki T, Mitsuhashi Y, Ito S, Kono M, Komine M, Akita H, Tomita Y: Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes. J Dermatol. 2008, 35: 395-406.CrossRefPubMed

Hou YX, Chen JJ, Gao M, Zhou FS, Du WH, Shen KJ, Yang S, Zhang XJ: Five novel mutations of RNA-specific adenosine deaminase gene with dyschromatosis symmetrica hereditaria. Acta Derm Venereol. 2007, 87: 18-21.CrossRefPubMed

Liu Q, Jiang L, Liu WL, Kang XJ, Ao Y, Sun M, Luo Y, Song Y, Lo WH, Zhang X: Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. Br J Dermatol. 2006, 154: 636-642.CrossRefPubMed

Gao JL, Liu Q, Liu X, Ji CY, Qu SQ, Wang SS, Luo Y: Cyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling. PLoS One. 2014, 9 (3): e89884-CrossRefPubMedPubMedCentral

Liu Q, Liu X, Gao J, Shi X, Hu X, Wang SS, Luo Y: Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation. Int J Biol Sci. 2013, 9 (6): 541-549.CrossRefPubMedPubMedCentral

Li CR, Li M, Ma HJ, Luo D, Yang LJ, Wang DG, Zhu XH, Yue XZ, Chen WQ, Zhu XY: A new arginine substitution mutation of DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2005, 37 (2): 95-99.CrossRefPubMed

Murata I, Hozumi Y, Kawaguchi M, Katagiri Y, Yasumoto S, Kubo Y, Fujimoto W, Horikawa T, Kondo T, Kono M, Tomita Y, Suzuki T: Four novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2009, 53: 76-77.CrossRefPubMed

10.

Wang Q: RNA editing catalyzed by ADAR1 and its function in mammalian cells. Biochemistry (Mosc). 2011, 76: 900-911.CrossRef

11.

Bass BL: RNA editing by adenosine deaminases that act on RNA Annu. Rev Biochem. 2002, 71: 817-846.CrossRef

12.

Brooks PJ: The case for 8, 5′-cyclopurine-2′-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007, 145: 1407-1417.CrossRefPubMed

13.

Liu Q, Liu W, Jiang L, Sun M, Ao Y, Zhao X, Song Y, Luo Y, Lo WH, Zhang X: Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. J Invest Dermatol. 2004, 122: 896-899.CrossRefPubMed

14.

Cho DS, Yang W, Lee JT, Shiekhatter R, Murray JM, Nishikura K: Requirement of dimerization for RNA editing activity of adenosine deaminase acting on RNA. J Biol Chem. 2003, 278: 17093-17102.CrossRefPubMed

15.

Kantaputra PN, Chinadet W, Ohazama A, Kono M: Dyschromatosis symmetrica hereditaria with long hair on the forearms, hypo/hyperpigmented hair, and dental anomalies: report of a novel ADAR1 mutation. Am J Med Genet A. 2012, 158A (9): 2258-2265.CrossRefPubMed

16.

Murata I, Hayashi M, Hozumi Y, Fujii K, Mitsuhashi Y, Oiso N, Fukai K, Kuroki N, Mori Y, Utani A, Tomita Y, Fujita Y, Suzuki T: Mutation analyses of patients with dyschromatosis symmetrica hereditaria: five novel mutations of the ADAR1 gene. J Dermatol Sci. 2010, 58: 218-220.CrossRefPubMed

17.

Wang XP, Liu Y, Wang JM, Xiao SX: Two novel splice site mutations of the ADAR1 gene in Chinese families with dyschromatosis symmetrica hereditaria. J Dermatol. 2010, 37: 1051-1052.CrossRefPubMed

18.

Li M, Jin C, Yang L, Lai M, Yao Z: A novel complex insertion-deletion mutation in ADAR1 gene in a Chinese family with dyschromatosis symmetrica hereditaria. J Eur Acad Dermatol Venereol. 2011, 25: 743-746.CrossRefPubMed

19.

Wang XP, Wang WJ, Wang JM, Liu Y, Xiao SX: Four novel and two recurrent mutations of the ADAR1 gene in Chinese patients with dyschromatosis symmetrica hereditaria. J Dermatol Sci. 2010, 58: 217-218.CrossRefPubMed

20.

Liu H, Fu XA, Yu YX, Yu GQ, Yan XX, Liu HX, Tian HQ, Zhang FR: Identification of two novel splice mutations of the ADAR1 gene in two Chinese families with dyschromatosis symmetrica hereditaria. Clin Exp Dermatol. 2011, 36: 797-799.CrossRefPubMed

21.

Kono M, Akiyama M, Kondo T, Suzuki T, Suganuma M, Wataya-Kaneda M, Lam J, Shibaki A, Tomita Y: Four novel ADAR1 gene mutations in patients with dyschromatosis symmetrica hereditaria. J Dermatol. 2012, 39: 819-821.CrossRefPubMed

22.

Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Lizasa H, Davuluri RV, Nishikura K: ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell. 2013, 153 (3): 575-589.CrossRefPubMedPubMedCentral

23.

Qiu W, Wang X, Buchanan M, He K, Sharma R, Zhang L, Wang Q, Yu J: ADAR1 is essential for intestinal homeostasis and stem cell maintenance. Cell Death Dis. 2013, 4: e599-CrossRefPubMedPubMedCentral

24.

Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirch J, Jacoby E, Rivkin L, Eyal E, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel G: MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest. 2013, 123 (6): 2703-2718.CrossRefPubMedPubMedCentral

25.

Nishikura K, Sakurai M, Ariyoshi K, Ota H: Antagonistic and stimulative roles of ADAR1 in RNA silencing. RNA Biol. 2013, 10 (8): 1240-1247.CrossRefPubMedPubMedCentral

26.

Tojo K, Sekijima Y, Suzuki T, Suzuki N, Tomita Y, Yoshida K, Hashimoto T, Ikeda S: Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov Disord. 2006, 21: 1510-1513.CrossRefPubMed

27.

Rice GI, Kasher PR, Fort GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, Jenkinson EM, Bacino CA, Battini R, Bertini E, Brogan PA, Brueton LA, Carpanelli M, De Laet C, de Lonlay P, del Toro M, Desquerre I, Fazzi E, Garcia-Cazorla A, Heiberg A, Kawaquchi M, Kunar R, Lin JP, Lourenco CM, Male AM, Marques W, et al: Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet. 2012, 44: 1243-1248.CrossRefPubMedPubMedCentral

28.

Suzuki N, Suzuki T, Inagaki K, Ito S, Kono M, Fukai K, Takama H, Sato K, Ishikawa O, Abe M, Shimizu H, Kawai M, Horikawa T, Yoshida K, Matsumoto K, Terui T, Tsujioka K, Tomita Y: Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. J Invest Dermatol. 2005, 124: 1186-1192.CrossRefPubMed

29.

Zhang JY, Chen XD, Zhang Z, Wang HL, Guo L, Liu Y, Zhao XZ, Cao W, Xing QH, Shao FM: The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria. Br J Dermatol. 2013, 169 (3): 637-644.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/15/69/prepub

Title: Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria
Authors: Qi Liu
Zhen Wang
Yuhong Wu
Lihua Cao
Qingzhu Tang
Xuesha Xing
Hongwei Ma
Shifa Zhang
Yang Luo
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Medical Genetics / Issue 1/2014
Electronic ISSN: 1471-2350
DOI: https://doi.org/10.1186/1471-2350-15-69

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study

Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations

A novel MIPgene mutation associated with autosomal dominant congenital cataracts in a Chinese family

Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease

The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile